ACE-Inhibitory and Antioxidant Activity of Temporin-Ra Peptide: Biochemical Characterization and Molecular Modeling Study
Abstract In this study, the inhibitory effect of Temporin-Ra (FP-14 peptide) on angiotensin converting enzyme (ACE) was evaluated. Inhibition mechanism was investigated by kinetic studies and molecular docking simulation. Lineweaver–Burk plot revealed that Temporin-Ra behaved as a non-competitive ACE inhibitor supported by the docking simulation. The $ IC_{50} $ and $ K_{i} $ values were determined to be 22.19 μM and 36 µg/ml, respectively. Molecular docking simulation showed that Temporin-Ra bound to both of N- and C-domains of ACE by forming hydrogen bonds and electrostatic interactions; Temporin-Ra displayed higher affinity to C-domain than N-domain. Antioxidant activity of Temporin-Ra was examined using different methods. The antioxidant activity of Temporin-Ra (0.2 mg/ml) in the inhibition of linoleic acid autoxidation was evaluated to be 57 %. 1,1-diphenyl-2-picrylhydrazyl and 2, 2-azino-bis (3-ethylbenzothiazoline-6-sulphonicacid) diammonium salt radicals scavenging activities were 60 % at 0.5 mg/ml and 37 % at 0.3 mg/ml, respectively. The hydroxyl radical scavenging of FP-14 peptide at 0.33 mg/ml was 55 %. The results suggest that Temporin-Ra is a multifunctional peptide that could be exploited to develop new anti-hypertension drugs and bio-compatible natural antioxidants..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Letters in peptide science - 20(2014), 4 vom: 16. Juli, Seite 493-500 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mojallal-Tabatabaei, Zahra [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Angiotensin I-converting enzyme |
doi: |
10.1007/s10989-014-9416-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR015390683 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR015390683 | ||
003 | DE-627 | ||
005 | 20230519081823.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201006s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10989-014-9416-x |2 doi | |
035 | |a (DE-627)SPR015390683 | ||
035 | |a (SPR)s10989-014-9416-x-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |q ASE |
084 | |a 35.76 |2 bkl | ||
100 | 1 | |a Mojallal-Tabatabaei, Zahra |e verfasserin |4 aut | |
245 | 1 | 0 | |a ACE-Inhibitory and Antioxidant Activity of Temporin-Ra Peptide: Biochemical Characterization and Molecular Modeling Study |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract In this study, the inhibitory effect of Temporin-Ra (FP-14 peptide) on angiotensin converting enzyme (ACE) was evaluated. Inhibition mechanism was investigated by kinetic studies and molecular docking simulation. Lineweaver–Burk plot revealed that Temporin-Ra behaved as a non-competitive ACE inhibitor supported by the docking simulation. The $ IC_{50} $ and $ K_{i} $ values were determined to be 22.19 μM and 36 µg/ml, respectively. Molecular docking simulation showed that Temporin-Ra bound to both of N- and C-domains of ACE by forming hydrogen bonds and electrostatic interactions; Temporin-Ra displayed higher affinity to C-domain than N-domain. Antioxidant activity of Temporin-Ra was examined using different methods. The antioxidant activity of Temporin-Ra (0.2 mg/ml) in the inhibition of linoleic acid autoxidation was evaluated to be 57 %. 1,1-diphenyl-2-picrylhydrazyl and 2, 2-azino-bis (3-ethylbenzothiazoline-6-sulphonicacid) diammonium salt radicals scavenging activities were 60 % at 0.5 mg/ml and 37 % at 0.3 mg/ml, respectively. The hydroxyl radical scavenging of FP-14 peptide at 0.33 mg/ml was 55 %. The results suggest that Temporin-Ra is a multifunctional peptide that could be exploited to develop new anti-hypertension drugs and bio-compatible natural antioxidants. | ||
650 | 4 | |a Angiotensin I-converting enzyme |7 (dpeaa)DE-He213 | |
650 | 4 | |a Antioxidant |7 (dpeaa)DE-He213 | |
650 | 4 | |a Bioactive peptides |7 (dpeaa)DE-He213 | |
650 | 4 | |a Molecular modeling |7 (dpeaa)DE-He213 | |
700 | 1 | |a Asoodeh, Ahmad |e verfasserin |4 aut | |
700 | 1 | |a Asadi, Fatemeh |e verfasserin |4 aut | |
700 | 1 | |a Nezafati, Hamid Reza |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Letters in peptide science |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1994 |g 20(2014), 4 vom: 16. Juli, Seite 493-500 |w (DE-627)SPR015385973 |w (DE-600)2007589-3 |x 1573-496X |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2014 |g number:4 |g day:16 |g month:07 |g pages:493-500 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10989-014-9416-x |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 35.76 |q ASE |
951 | |a AR | ||
952 | |d 20 |j 2014 |e 4 |b 16 |c 07 |h 493-500 |